International and Racial Differences in Mineral and Bone Disorder Markers and Treatments Over the First 5 Years of Hemodialysis in the Dialysis Outcomes and Practice Patterns Study

International and Racial Differences in Mineral and Bone Disorder Markers and Treatments Over the First 5 Years of Hemodialysis in the Dialysis Outcomes and Practice Patterns Study

Rationale & Objective: Normalization of parathyroid hormone (PTH), serum calcium, and phosphorus levels may prevent coronary and bone disease in hemodialysis (HD) patients. We describe the trajectory of these mineral bone disorder parameters and treatments during the first 5 years of HD by inter...

Full description

Bibliographic Details
Main Authors: Kevin Chan, Angelo Karaboyas, Hal Morgenstern, Bruce M. Robinson, Friedrich K. Port, Stefan H. Jacobson, Masafumi Fukagawa, Yvonne Meier, Philipp A. Csomor, Ronald L. Pisoni
Format: Article
Language:English
Published: Elsevier 2019-05-01
Series:Kidney Medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2590059519300342

Internet

http://www.sciencedirect.com/science/article/pii/S2590059519300342

Similar Items